It's all in what you say and how you say it Lexology (registration) Subsequently, scientists found that rituximab could be used to treat another blood cancer, i.e., chronic lymphocytic leukemia (CLL), and Biogen filed a patent application based on this finding. This patent issued as US Patent No. 7,682,612, with claim ... |
